Case Report: Immune Dysregulation Due to Toxoplasma gondii Reactivation After Allogeneic Hematopoietic Cell Transplant
Robert B. Lindell(Children's Hospital of Philadelphia), Kathleen Chiotos(Children's Hospital of Philadelphia), W Otto(Children's Hospital of Philadelphia), Paisit Paueksakon(Monroe Carell Jr. Children's Hospital), Carrie L. Kitko(Vanderbilt University Medical Center), Michael A. Silverman(Children's Hospital of Philadelphia), Alicia M. Alcamo(Children's Hospital of Philadelphia), Timothy S. Olson(Children's Hospital of Philadelphia), Daniel E. Dulek(Vanderbilt University Medical Center), Michael S. Wolf(Georgia Institute of Technology)
Cited by 5
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
|JAMA|2015|420
A biomarker panel for acute graft-versus-host disease
|Blood|2008|404
Cutaneous Malignant Melanoma
|Mayo Clinic Proceedings|2006|364